FDA warns Novo Nordisk in Plainsboro, NJ, about its failure to meet postmarketing adverse drug experience reporting requirements.
Five Sidley attorneys recommend ways in which drug companies can analyze their direct-to-consumer promotions to see if they are likely to run afoul of FDA’s crackdown on such ads.
FDA warns Novo Nordisk in Plainsboro, NJ, about its failure to meet postmarketing adverse drug experience reporting requirements.
Five Sidley attorneys recommend ways in which drug companies can analyze their direct-to-consumer promotions to see if they are likely to run afoul of FDA’s crackdown on such ads.
FDA warns France’s Fareva about CGMP violations in the production of finished drugs at its Morton Grove, IL, manufacturing facility.
The Institute for Safe Medicines calls on FDA, the Federal Trade Commission, and the Department of Justice to take enforcement action against Hims & Hers for its Super Bowl TV ad promoting unapproved compounded drugs through unsubstantiated and misleading claims.
